This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 20 and 40
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to assess the bioequivalence of Levetiracetam versus Keppra administered under fasting conditions to healthy adult subjects.

Provided treatments

  • Drug: Levetiracetam (Lotus Pharmaceutical Co.,Ltd.)
  • Drug: Keppra (Levetiracetam - USB SA Pharma Sector)
Tris trial is registered with FDA with number: NCT00926302. The sponsor of the trial is Tri-Service General Hospital and it is looking for 26 volunteers for the current phase.
Official trial title:
A Randomized, Single, Two-Way Crossover Pivotal Study to Assess the Bioequivalence Study of Levetiracetam vs. Keppra Administered Under Fasting Conditions to Healthy Adult Subject